Category: Pharmaceuticals
Pharmaceuticals market research reports by Plunkett Research, Ltd.
-
Ultragenyx Pharmaceutical Inc (RARE:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Ultragenyx Pharmaceutical Inc (RARE:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Ultragenyx Pharmaceutical Inc (RARE:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Indus ... Read More
-
Vanda Pharmaceuticals Inc (VNDA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Vanda Pharmaceuticals Inc (VNDA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Vanda Pharmaceuticals Inc (VNDA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key ... Read More
-
Pfizer Inc (PFE:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Pfizer Inc (PFE:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Pfizer Inc (PFE:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new repor ... Read More
-
Aclaris Therapeutics Inc (ACRS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Aclaris Therapeutics Inc (ACRS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Aclaris Therapeutics Inc (ACRS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key F ... Read More
-
Halozyme Therapeutics Inc (HALO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Halozyme Therapeutics Inc (HALO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Halozyme Therapeutics Inc (HALO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key ... Read More
-
Bristol-Myers Squibb Company (BMY:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Bristol-Myers Squibb Company (BMY:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Bristol-Myers Squibb Company (BMY:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. ... Read More
-
Plunkett's Health Care Industry Almanac 2024: Health Care Industry Market Research, Statistics, Trends and Leading Companies
PLUNKETT'S HEALTH CARE INDUSTRY ALMANAC 2024 Key Findings: A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms within the Health Care Industry. Gain vital insights that can help shape strategy for business developme ... Read More
-
Scientific Research and Development (R&D) in Life Sciences, Medical Devices, Biotechnology and Pharmaceuticals (Drugs) (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 541711
Scientific Research and Development (R&D) in Life Sciences, Medical Devices, Biotechnology and Pharmaceuticals (Drugs) Industry (U.S.): Analytics, Extensive Financial Metrics, Benchmarks Against Averages and Top Companies Within Its Industry, and Revenue Forecasts to 2030, NAIC 541711 Vital indu ... Read More
-
Scientific Research and Development (R&D) in Physics, Engineering, Life Sciences, Drugs, Telecommunications and Electronics (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 541710
Scientific Research and Development (R&D) in Physics, Engineering, Life Sciences, Drugs, Telecommunications and Electronics Industry (U.S.): Analytics, Extensive Financial Metrics, Benchmarks Against Averages and Top Companies Within Its Industry, and Revenue Forecasts to 2030, NAIC 541710 Vital ... Read More
-
AmerisourceBergen Corporation (ABC:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
AmerisourceBergen Corporation (ABC:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry AmerisourceBergen Corporation (ABC:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industr ... Read More
-
McKesson Corporation (MCK:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
McKesson Corporation (MCK:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry McKesson Corporation (MCK:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings: T ... Read More
-
Merck & Co Inc (MRK:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Merck & Co Inc (MRK:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Merck & Co Inc (MRK:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings: This unique n ... Read More
-
Johnson & Johnson (JNJ:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Johnson & Johnson (JNJ:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Johnson & Johnson (JNJ:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings: This un ... Read More
-
Plunkett's Biotech, Pharmaceuticals & Genetics Industry Almanac 2024: Biotech, Pharmaceuticals & Genetics Industry Market Research, Statistics, Trends and Leading Companies
PLUNKETT'S BIOTECH, PHARMACEUTICALS & GENETICS INDUSTRY ALMANAC 2024 Key Findings: A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms within the Biotech, Pharmaceuticals & Genetics Industry. Gain vital insights tha ... Read More
-
Scientific Research and Development (R&D) in Life Sciences, Medical Devices, Biotechnology and Pharmaceuticals (Drugs) (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2027, NAIC 541711
Scientific Research and Development (R&D) in Life Sciences, Medical Devices, Biotechnology and Pharmaceuticals (Drugs) Industry (U.S.): Analytics, Extensive Financial Metrics, Benchmarks Against Averages and Top Companies Within Its Industry, and Revenue Forecasts to 2030, NAIC 541711 Vital industry ... Read More
-
Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2027, NAIC 424200
Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors Industry (U.S.): Analytics, Extensive Financial Metrics, Benchmarks Against Averages and Top Companies Within Its Industry, and Revenue Forecasts to 2030, NAIC 424200 Vital industry-specific data including metrics, benchmarks, historic ... Read More
-
Tarsus Pharmaceuticals Inc (TARS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Tarsus Pharmaceuticals Inc (TARS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Tarsus Pharmaceuticals Inc (TARS:NAS) compared to its top competitors and compar ... Read More
-
Timber Pharmaceuticals Inc (TMBR:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Timber Pharmaceuticals Inc (TMBR:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Timber Pharmaceuticals Inc (TMBR:ASE) compared to its top competitors and compar ... Read More
-
Acer Therapeutics Inc (ACER:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Acer Therapeutics Inc (ACER:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Acer Therapeutics Inc (ACER:NAS) compared to its top competitors and compared to the ... Read More
-
Navidea Biopharmaceuticals Inc (NAVB:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Navidea Biopharmaceuticals Inc (NAVB:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Navidea Biopharmaceuticals Inc (NAVB:ASE) compared to its top competitors an ... Read More
-
Syndax Pharmaceuticals (SNDX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Syndax Pharmaceuticals (SNDX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Syndax Pharmaceuticals (SNDX:NAS) compared to its top competitors and compared to th ... Read More
-
Apellis Pharmaceuticals (APLS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Apellis Pharmaceuticals (APLS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Apellis Pharmaceuticals (APLS:NAS) compared to its top competitors and compared to ... Read More
-
Rhythm Pharmaceuticals (RYTM:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Rhythm Pharmaceuticals (RYTM:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Rhythm Pharmaceuticals (RYTM:NAS) compared to its top competitors and compared to th ... Read More
-
Actinium Pharmaceuticals Inc (ATNM:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Actinium Pharmaceuticals Inc (ATNM:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Actinium Pharmaceuticals Inc (ATNM:ASE) compared to its top competitors and co ... Read More
-
Aerie Pharmaceuticals Inc (AERI:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Aerie Pharmaceuticals Inc (AERI:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Aerie Pharmaceuticals Inc (AERI:NAS) compared to its top competitors and compared ... Read More
Research Assistance
